The E – nose that can “smell” lung cancer in a person’s breath – MSKCC
Memorial Sloan Kettering Cancer Center shared a post on LinkedIn:
“A team led by Dr. Gaetano Rocco, a thoracic surgeon at Memorial Sloan Kettering Cancer Center (MSK), reported promising results in a clinical trial that tested a screening method known as “E-nose.”
The E-nose uses technology that can “smell” lung cancer in a person’s breath. “Chemicals called volatile organic compounds (VOCs) are emitted by cancer cells,” Dr. Rocco explains. “And they can be detected even at early stages of the disease.”
The trial raises hopes that E-nose could become an important tool in detecting lung cancer because the approach is noninvasive, highly accurate, inexpensive — and may one day even be small enough to slip inside a clinician’s pocket.
“E-nose could be a valuable addition to diagnosing and treating lung cancer,” he says, “and MSK’s expertise and leadership in the field means it’s the right place to make this a reality.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023